AVTX SEC Form 4 filings
Avalo Therapeutics, Inc. Latest Insider Trading Activity
Over the past 1,679 days, 20 insider trades from Avalo Therapeutics, Inc. (AVTX). The most recent SEC Form 4 filing shows a sale by Sullivan Christopher Ryan (Avalo Therapeutics, Inc. Chief Financial Officer) on September 16, 2026 involving 12,394 shares at $16.33 per share. This page shows up to the 10 most recent SEC Form 4 filing records on a 6-hour delay. Sign up for real-time updates and access to 20 years of historic insider trading data.
Insider Trading For AVTX Charted on Daily Candles. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-09-18 | 2026-09-16 | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 1 | 12,394 | $16.33 | $202,437.40 | 23.70% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-06-01 | 2026-05-28 | Avalo Therapeutics, Inc. | Doyle Mittie | Chief Medical Officer | Sell | 1 | 679 | $16.00 | $10,864.00 | 1.42% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-05-19 | 2026-05-15 | Avalo Therapeutics, Inc. | Doyle Mittie | Chief Medical Officer | Sell | 1 | 3,000 | $18.76 | $56,280.00 | 45.30% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-05-11 | 2026-05-07 | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 1 | 18,606 | $24.12 | $448,776.72 | 97.78% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-05-07 | 2026-05-06 | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Chief Financial Officer | Sell | 5 | 47,000 | $20.18 | $948,605.89 | 36.12% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-05-07 | 2026-05-06 | Avalo Therapeutics, Inc. | Chan Mitchell | Director | Sell | 1 | 3,167 | $22.88 | $72,460.96 | 50.01% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-05-07 | 2026-05-06 | Avalo Therapeutics, Inc. | Varki Paul | Chief Legal Officer | Sell | 5 | 75,063 | $20.17 | $1,513,708.81 | 43.27% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction AVTX | 2026-04-03 | 2026-04-01 | Avalo Therapeutics, Inc. | Doyle Mittie | Chief Medical Officer | Sell | 1 | 679 | $16.00 | $10,864.00 | 15.79% | View Filing |
| ESPP: Employee share purchase program AVTX | 2023-06-13 | 2023-06-09 | Avalo Therapeutics, Inc. | Neil Garry Arthur | CEO and Chairman of the Board | Buy | 1 | 4,000 | $3.42 | $13,680.00 | 30.26% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. AVTX | 2022-03-14 | 2022-03-14 | Avalo Therapeutics, Inc. | Boyd Steven | Director,TenPercentOwner | Buy | 3 | 226,000 | $0.67 | $152,200.00 | 0.16% | View Filing |
⚠️ THE SAMPLE ABOVE IS DEFERRED BY 6 HOURS ⚠️
Start your 2-week, no-credit-card free trial today to receive get down to the second insider trading updates in this directory or email.
Pricing
Free Trial
10 trading days$0
Explore every Premium feature before you pay.
- Full platform access
- 10 trading days
- No credit card required
- 20 years of alert history
- Live alert directory updates
Standard Monthly
Scheduled$19.99 / month
Scheduled alerts with complete trade context.
- Email and Telegram delivery
- Alert intervals from every sixty minutes to once daily
- Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
- Highlighted cluster transactions and SEC filing links
- Access to the alert directory hourly refreshes
Premium Monthly
Recommended$29.99 / month
Fastest alerts with ticker-level control.
- Everything in Standard
- Instant delivery detection-to-outbound time averages 0.88 seconds
- Alert intervals starting from one minute
- Real time alert directory updates
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.